Valvular heart disease

• Thrombocytopenia after transcatheter aortic valve implantation

  Gabriela Tirado-Conte, Vassili Panagides, Carlos E. Vergara-Uzcategui, Gabriela Veiga Fernández, Jean Paul Vílchez, Pedro Cepas-Guillén, Juan Francisco Oteo, Alejandro Barrero, Luis Marroquín, Julio I. Farjat-Pasos, Ketina Arslani, Pilar Jiménez-Quevedo, Iván Núñez-Gil, Hernán Mejía-Rentería, José M. de la Torre Hernández, José Luis Díez Gil, Ander Regueiro, Ignacio Amat-Santos, Antonio Fernández-Ortiz, Guering Eid-Lidt, Ole de Backer, Josep Rodés-Cabau, Luis Nombela-Franco

  Rev Esp Cardiol. 2025;78:347-57

• Late bleeding events in TAVI patients receiving vitamin K antagonists or direct oral anticoagulants

  Alberto Alperi, Raul Ptaszynski, Isaac Pascual, Raquel del Valle, Daniel Hernández-Vaquero, Marcel Almendárez, Paula Antuna, Raul Ludeña, César Morís, Pablo Avanzas

  Rev Esp Cardiol. 2024;77:976-84

• Description and prevalence of ventricular mitral annular disjunction: variation of normality or pathological variant?

  Agata Krawczyk-Ożóg, Mateusz K. Hołda, Jakub Batko, Kacper Jaśkiewicz, Artur Dziewierz, Barbara Zdzierak, Wojciech Zasada, Krzysztof Gil, Jakub Hołda

  Rev Esp Cardiol. 2024;77:987-94

• Valvulitis: a new echocardiographic criterion for the diagnosis of bioprosthetic aortic valve infective endocarditis

  Pablo Zulet, Isidre Vilacosta, Eduardo Pozo, Daniel García-Arribas, Carlos Nicolás Pérez-García, Manuel Carnero, Daniel Pérez-Camargo, Lourdes Montero, Melchor Saiz-Pardo, Patricia Mahía, Adrián Jerónimo, Fabián Islas, Daniel Gómez, José Alberto San Román, José Alberto de Agustín, Carmen Olmos

  Rev Esp Cardiol. 2024;77:859-67

• Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes

  Sergio García-Blas, Vicente Pernias, Jessika González D’Gregorio, Agustín Fernández-Cisnal, Clara Bonanad, Clara Sastre, Ernesto Valero, Gema Miñana, Georgiana Zaharia, Julio Núñez, Juan Sanchis

  Rev Esp Cardiol. 2024;77:750-8

• Angina in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

  Lukas S. Keller, Jorge Nuche, Marisa Avvedimento, Carlos Real, Julio Farjat-Pasos, Jean-Michel Paradis, Robert DeLarochellière, Anthony Poulin, Dimitris Kalavrouziotis, Eric Dumont, Attilio Galhardo, Siddhartha Mengi, Siamak Mohammadi, Josep Rodés-Cabau

  Rev Esp Cardiol. 2023;76:991-1002

• The 4A classification for patients with tricuspid regurgitation

  Ariana González-Gómez, Covadonga Fernández-Golfín, Rocío Hinojar, Juan Manuel Monteagudo, Ana García, Cristina García-Sebastián, Inés García-Lunar, Ángel Sánchez-Recalde, Luisa Salido, Ana Pardo, José Luis Zamorano

  Rev Esp Cardiol. 2023;76:845-51

• Soluble ST2 levels are related to replacement myocardial fibrosis in severe aortic stenosis

  Vanessa Arrieta, Eva Jover, Adela Navarro, Ernesto Martín-Núñez, Mattie Garaikoetxea, Lara Matilla, Amaia García-Peña, Amaya Fernández-Celis, Alicia Gainza, Virginia Álvarez, Rafael Sádaba, Natalia López-Andrés

  Rev Esp Cardiol. 2023;76:679-89

• DOAC versus VKA in patients with atrial fibrillation and bioprosthetic valves: a systematic review and meta-analysis

  Paula Guardia Martínez, Alberto Luis Avilés Toscano, María Asunción Martínez Mayoral, Josep Moltó Miralles

  Rev Esp Cardiol. 2023;76:690-9

• Quantification of right atrial fibrosis by cardiac magnetic resonance: verification of the method to standardize thresholds

  Clara Gunturiz-Beltrán, Roger Borràs, Francisco Alarcón, Paz Garre, Rosa M. Figueras i Ventura, Eva M. Benito, Gala Caixal, Till F. Althoff, José María Tolosana, Elena Arbelo, Ivo Roca-Luque, Susanna Prat-González, Rosario Jesús Perea, Josep Brugada, Marta Sitges, Eduard Guasch, Lluís Mont

  Rev Esp Cardiol. 2023;76:173-82

• Time trends in the epidemiology of nonrheumatic aortic valve disease in Spain, 2003-2018

  Nicolás Rosillo, Lourdes Vicent, David Martín de la Mota Sanz, Francisco Javier Elola, Guillermo Moreno, Héctor Bueno

  Rev Esp Cardiol. 2022;75:1020-8

• Impact of renin-angiotensin system inhibitors on outcomes after surgical or transcatheter aortic valve replacement. A meta-analysis

  Ignacio J. Amat-Santos, Sandra Santos-Martínez, Fabián Julca, Pablo Catalá, Tania Rodríguez-Gabella, Alfredo Redondo-Diéguez, Williams Hinojosa, Carlos Veras, Alberto Campo, Ana Serrador Frutos, Manuel Carrasco-Moraleja, José A. San Román

  Rev Esp Cardiol. 2021;74:421-6

• Multimodality evaluation of transcatheter structural valve degeneration at long-term follow-up

  Alfredo Nunes Ferreira-Neto, Tania Rodriguez-Gabella, Leonardo Guimaraes, Afonso Freitas-Ferraz, Mathieu Bernier, Camila Figueiredo Guimaraes, Sergio Pasian, Jean-Michel Paradis, Robert Delarochellière, Eric Dumont, Siamak Mohammadi, Dimitri Kalavrouziotis, Mélanie Côté, Philippe Pibarot, Josep Rodés-Cabau

  Rev Esp Cardiol. 2021;74:247-56

• Asymptomatic aortic stenosis in a geriatric population. The role of frailty and comorbidity in mortality

  Mónica Ramos, Maribel Quezada, Rocío Ayala, Francisco Javier Gómez-Pavón, Javier Jaramillo, María Calderón-Domínguez, Rocío Toro

  Rev Esp Cardiol. 2021;74:167-74

• Prognostic value of aortic valve area normalized to body size in native aortic stenosis

  Sergio Gamaza Chulián, Enrique Díaz Retamino, Rocío Carmona García, Bárbara Serrano Muñoz, Javier León Jiménez, Soraya González Estriégana, Jesús Oneto Otero

  Rev Esp Cardiol. 2021;74:44-50

• Predictive model of in-hospital mortality in left-sided infective endocarditis

  Pablo Elpidio García-Granja, Javier López, Isidre Vilacosta, Cristina Sarriá, Fernando Domínguez, Raquel Ladrón, Carmen Olmos, Carmen Sáez, Silvia Vilches, Daniel García-Arribas, Marta Cobo-Marcos, Antonio Ramos, Luis Maroto, Itziar Gómez, Manuel Carrasco, Pablo García-Pavía, J. Alberto San Román

  Rev Esp Cardiol. 2020;73:902-9

• Short- and long-term mortality in patients with left-sided infective endocarditis not undergoing surgery despite indication

  Nuria Vallejo Camazón, Germán Cediel, Raquel Núñez Aragón, Lourdes Mateu, Cinta Llibre, Nieves Sopena, Francisco Gual, Elena Ferrer, María Dolores Quesada, Elisabeth Berastegui, Albert Teis, Jorge López Ayerbe, Gladys Juncà, Ainhoa Vivero, Christian Muñoz Guijosa, Lluisa Pedro-Botet, Antoni Bayés-Genís

  Rev Esp Cardiol. 2020;73:734-40

• Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants

  César Caro Martínez, Ginés Elvira Ruiz, Pedro J. Flores Blanco, Juan José Cerezo Manchado, Helena Albendín Iglesias, Alejandro Lova Navarro, Francisco Arregui Montoya, Arcadio García Alberola, Domingo Andrés Pascual Figal, José Luis Bailén Lorenzo, Sergio Manzano Fernández

  Rev Esp Cardiol. 2019;72:935-43

• Multicenter Evaluation of Prosthesis Oversizing of the SAPIEN 3 Transcatheter Heart Valve. Impact on Device Failure and New Pacemaker Implantations

  Costanza Pellegrini, Won-Keun Kim, Andreas Holzamer, Thomas Walther, N. Patrick Mayr, Jonathan Michel, Tobias Rheude, Julio Nuñez, Albert M. Kasel, Teresa Trenkwalder, Bernhard M. Kaess, Michael Joner, Adnan Kastrati, Heribert Schunkert, Michael Hilker, Helge Möllmann, Christian Hengstenberg, Oliver Husser

  Rev Esp Cardiol. 2019;72:641-8

• Prognosis of Patients With Severe Aortic Stenosis After the Decision to Perform an Intervention

  Hugo González Saldivar, Lourdes Vicent Alaminos, Carlos Rodríguez-Pascual, Gonzalo de la Morena, Covadonga Fernández-Golfín, Carmen Amorós, Mario Baquero Alonso, Luis Martínez Dolz, Albert Ariza Solé, Gabriela Guzmán-Martínez, Juan José Gómez-Doblas, Antonio Arribas Jiménez, María Eugenia Fuentes, Laura Galian Gay, Martín Ruiz Ortiz, Pablo Avanzas, Emad Abu-Assi, Tomás Ripoll-Vera, Oscar Díaz-Castro, Eduardo Pozo Osinalde, Eva Bernal, Manuel Martínez-Sellés

  Rev Esp Cardiol. 2019;72:392-7